Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2000, p. 2943-2948, Vol. 38, No. 8
Institute for Medical Microbiology and
Hygiene1 and Institute of Organic
Chemistry and Biochemistry,2 University of
Freiburg, Freiburg, and Max Planck Institute for Biology,
Tübingen,4 Germany; Institute
de Bactériologie de la Faculté de Médecine,
Université Louis-Pasteur, Strasbourg,
France3; and Division of Microbiology,
Biocenter of the University of Basel, Basel,
Switzerland5
Received 28 December 1999/Accepted 29 May 2000
Cat scratch disease (CSD) is a frequent clinical outcome of
Bartonella henselae infection in humans. Recently, two case
reports indicated Bartonella clarridgeiae as an additional
causative agent of CSD. Both pathogens have been isolated from domestic
cats, which are considered to be their natural reservoir. B. clarridgeiae and B. henselae can be
distinguished phenotypically by the presence or absence of flagella,
respectively. Separation of the protein content of purified flagella of
B. clarridgeiae by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and immunoblot analysis indicated that the
flagellar filament is mainly composed of a polypeptide with a mass of
41 kDa. N-terminal sequencing of 20 amino acids of this protein
revealed a perfect match to the N-terminal sequence of flagellin
(FlaA) as deduced from the sequence of the flaA gene cloned
from B. clarridgeiae. The flagellin of B. clarridgeiae is closely related to flagellins of Bartonella
bacilliformis and several Bartonella-related
bacteria. Since flagellar proteins are often immunodominant antigens,
we investigated whether antibodies specific for the FlaA protein of
B. clarridgeiae are found in patients with CSD or
lymphadenopathy. Immunoblotting with 724 sera of patients suffering
from lymphadenopathy and 100 healthy controls indicated specific FlaA
antibodies in 3.9% of the patients' sera but in none of the controls.
B. clarridgeiae FlaA is thus antigenic and expressed in
vivo, providing a valuable tool for serological testing. Our results
further indicate that B. clarridgeiae might
be a possible etiologic agent of CSD or lymphadenopathy. However, it
remains to be clarified whether antibodies to the FlaA protein of
B. clarridgeiae are a useful indicator of acute infection.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of Bartonella clarridgeiae Flagellin
(FlaA) and Detection of Antiflagellin Antibodies in Patients
with Lymphadenopathy
*
Corresponding author. Mailing address: Department of
Microbiology and Hygiene, Institute for Medical Microbiology and
Hygiene, University of Freiburg, Hermann-Herder-Str. 11, D-79104
Freiburg, Germany. Phone: (49) 761-203 6529. Fax: (49) 761-203 6562. E-mail: sander{at}ukl.uni-freiburg.de.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|